Your search for ‘Smart & Biggar’ returned 2,497 results

On March 10, 2020, the Government of Québec announced an incentive tax deduction for the commercialization of innovations ...

ENTRESTO (sacubitril-valsartan)

On May 29, 2019, the Canadian Government introduced Bill C-100, legislation designed to meet obligations included in the United States-Mexico-Canada Agreement (USMCA).

Le Gouvernement du Québec a annoncé, hier, que les modifications règlementaires sur l'affichage commercial en vertu de la Charte de la langue française entreront en vigueur le 24 novembre 2016.

Last year, the Ontario government convened an Expert Panel on Intellectual Property, chaired by Jim Balsillie. He has long advocated for publicly funded research and other institutions to take a...

The Canadian Intellectual Property Office (CIPO) has proposed amendments to the Trade-marks Regulations (Regulations) that would introduce significant procedural changes to trademark law in Canada, including the following

Over ten years have passed since the Federal Court of Appeal (FCA) flagged the patentability of methods of medical treatment as being worthy of full consideration by the Supreme Court of Canada. This issue has finally come before the Court.

The Board decision was quashed, and the case was sent back to the Board for redetermination.

On October 15, 2020, the Supreme Court of Canada granted applications brought by both York University and Access Copyright for leave to appeal the Federal Court ...

The Supreme Court of Canada announced today that it has granted leave to appeal to Apotex Inc. from the Federal Court of Appeal (FCA) in the patent case Sanofi-Aventis v. Apotex Inc. (reported here), in which the FCA allowed Sanofi’s action for infringement and dismissed Apotex’s action for impeachment (reported here).

The United States Supreme Court unanimously relaxed the standard for determining whether a successful patent litigant should be compensated for legal fees.

On April 27, 2020, the United States Patent and Trademark Office published a petition decision stating that under current law...

If yes, then examiners must evaluate whether the claim contains "significantly more" than the excluded concept.

The Canadian Intellectual Property Office has recently revised its Practice Notice regarding name and surname objections. The revised Practice Notice can be found here.

This is a chance for Canadians to review their European rights and to identify whether they should be seeking protection for additional marks, further specify goods/services or add new classes for existing marks.

The Federal Court in Premium Sports Broadcasting Inc. v. 9005-5906 Québec Inc. (Resto-bar Mirabel), 2017 FC 590, recently dismissed a copyright infringement action on a summary trial motion.

On March 1, 2012, the Ontario Superior Court of Justice found that a network of five national and international companies and three individuals (principals and employees of the companies) (respondents) violated the Competition Act for making false and misleading statements.

In Nycomed v. Teva, the Federal Court of Appeal confirmed that there is no cause of action in Canada for "contributory infringement" of a patent and, accordingly, approved a decision that struck out parts of a Statement of Defence and Counterclaim that pleaded it